419 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
JAZZ Jazz Pharmaceuticals plc $161.01 $9.73B N/A
Article Searches
3 Reasons Why Jazz (JAZZ) Is a Great Growth Stock http://www.zacks.com/stock/news/381267/3-reasons-why-jazz-jazz-is-a-great-growth-stock?cid=CS-ZC-FT-381267 Apr 16, 2019 - Jazz (JAZZ) could produce exceptional returns because of its solid growth attributes.
Clippers hang on to beat Jazz in OT on Ralph Lawler Night, will face Warriors in first-round series https://www.ocregister.com/2019/04/10/clippers-hang-on-to-beat-jazz-in-ot-on-ralph-lawler-night-will-face-warriors-in-first-round-series/ Apr 11, 2019 - The eighth-seeded Clippers open their best-of-seven series with two-time defending champion Golden State on Saturday at 5 p.m. in Oakland. Game 2 is Monday night, with the series shifting to Staples Center for Games 3 and 4 on Thursday (April 18) and Easter Sunday (April 21).
Fleetwood Mac cancels shows, including replacement gig at New Orleans jazz fest http://www.latimes.com/entertainment/la-et-ms-fleetwood-mac-cancels-shows-20190408-story.html Apr 08, 2019 -

The New Orleans jazz festival just can’t catch a break with the baby boomer bands.

Mere days after announcing that Fleetwood Mac would replace the Rolling Stones as a headliner on May 2, the fest is back to the drawing board after the news that Stevie Nicks has the flu and Fleetwood Mac won’t be...

Lakers keep surprising, knocking off Utah Jazz at home https://www.ocregister.com/2019/04/07/lakers-keep-surprising-knocking-off-utah-jazz-at-home/ Apr 08, 2019 - The Lakers (37-44) officially let youth take the wheel, giving Jemerrio Jones the nod in the starting lineup over Rajon Rondo, who did not play.
Jemerrio Jones has a big hand in helping Lakers turn back playoff-bound Jazz http://www.latimes.com/sports/lakers/la-sp-lakers-jazz-20190407-story.html Apr 07, 2019 -

After the Lakers’ 113-109 win over the Utah Jazz, Jemerrio Jones walked up to coach Luke Walton to thank him for the opportunity. He’s done it in each of the last five games — every time he’s had the pleasure of playing in the NBA.

“He means it,” Walton said. “He’s very thankful for the opportunity...

Utah Jazz guard Dante Exum slams down a few million for Venice pad http://www.latimes.com/business/realestate/hot-property/la-fi-hotprop-dante-exum-venice-home-20190403-story.html Apr 03, 2019 -

Dante Exum isn’t letting an injury stop him from making moves. The Utah Jazz point guard, who has been out of action since suffering a partially torn patellar tendon in mid-March, has bought a newly built home in Venice for $3.36 million.

Like many homes in the tightly packed beach city, the contemporary-style...

Jazz (JAZZ) Down 0.4% Since Last Earnings Report: Can It Rebound? http://www.zacks.com/stock/news/366079/jazz-jazz-down-04-since-last-earnings-report-can-it-rebound?cid=CS-ZC-FT-366079 Mar 28, 2019 - Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jazz stifle Lakers, guaranteeing them a losing record for a 6th straight season https://www.ocregister.com/2019/03/27/jazz-stifle-lakers-guaranteeing-them-a-losing-record-for-a-6th-straight-season/ Mar 28, 2019 - The severely short-handed Lakers were no match for Utah's Rudy Gobert-led defense in a 115-100 loss that denied them their first three-game win streak since November.
Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study http://www.zacks.com/stock/news/365755/jazzs-xyrem-follow-on-drug-succeeds-in-phase-iii-study?cid=CS-ZC-FT-365755 Mar 27, 2019 - Jazz Pharmaceuticals (JAZZ) announced positive top-line data from its phase III study on low sodium formulation of Xyrem, JZP-258.
The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO http://feeds.benzinga.com/~r/benzinga/~3/zGatNb7Nq3E/the-daily-biotech-pulse-fda-nod-for-novartis-jazz-positive-late-stage Mar 27, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech stocks hitting 52-week highs on March 26)

read more

Pages: 12345678910...42

<<<Page 5>